agree. I’m big on looking at comparable trials to see how recruitment went as that’s often a good guide to the scale of the challenge . Take MPACT panc cancer trial I referred to before (gemcitabine + abraxane) . The published study says it took about 3 years with 150 sites to get 860 patients. That’s about 2 patients per site per year. Unless you think there’s a reason why ACCENT can substantially outperform MPACT , then I’d be using that estimate as a guide.
If that plays out here, with 11 sites, then could take at least a year to get this 26….
- Forums
- ASX - By Stock
- ATX
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-44
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
|
|||||
Last
6.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.67M |
Open | High | Low | Value | Volume |
6.4¢ | 6.4¢ | 6.1¢ | $9.419K | 149.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 39253 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.1¢ | 12705 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 39253 | 0.060 |
3 | 77817 | 0.059 |
3 | 100991 | 0.058 |
2 | 62105 | 0.057 |
1 | 78520 | 0.056 |
Price($) | Vol. | No. |
---|---|---|
0.061 | 12705 | 1 |
0.070 | 12509 | 2 |
0.075 | 335646 | 1 |
0.079 | 3000 | 1 |
0.080 | 200000 | 1 |
Last trade - 15.59pm 22/07/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |